143 related articles for article (PubMed ID: 4674034)
1. Effects of aporphine and emetine alkaloids on central dopaminergic mechanisms in rats.
Lal S; Sourkes TL; Missala K; Belendiuk G
Eur J Pharmacol; 1972 Oct; 20(1):71-9. PubMed ID: 4674034
[No Abstract] [Full Text] [Related]
2. Effect of psychotropic drugs on tryptophan concentration in the rat brain.
Tagliamonte A; Tagliamonte P; Perez-Cruet J; Stern S; Gessa GL
J Pharmacol Exp Ther; 1971 Jun; 177(3):475-80. PubMed ID: 4328018
[No Abstract] [Full Text] [Related]
3. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.
Miller RJ; Kelly PH; Neumeyer JL
Eur J Pharmacol; 1976 Jan; 35(1):77-83. PubMed ID: 943290
[TBL] [Abstract][Full Text] [Related]
4. Reticuline: a dopamine receptor blocker.
Banning JW; Uretsky NJ; Patil PN; Beal JL
Life Sci; 1980 Jun; 26(24):2083-91. PubMed ID: 7190206
[No Abstract] [Full Text] [Related]
5. Neuroleptic-like, anticonvulsant and antinociceptive effects of aporphine alkaloids: bulbocapnine, corytuberine, boldine and glaucine.
Zetler G
Arch Int Pharmacodyn Ther; 1988; 296():255-81. PubMed ID: 2907279
[TBL] [Abstract][Full Text] [Related]
6. Antidopaminergic effects of bisbenzyl and benzyl tetrahydroisoquinoline alkaloids.
Watanabe H; Uramoto H; Maeda-Hagiwara M; Kikuchi T
Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):53-60. PubMed ID: 3938207
[TBL] [Abstract][Full Text] [Related]
7. The role of dopamine in pilocarpine-induced catalepsy.
Ahtee L; Kääriäinen I
Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(1):25-38. PubMed ID: 4279348
[No Abstract] [Full Text] [Related]
8. Catalepsy and stereotyped behaviour in rats treated chronically with methadone: relation to brain homovanillic acid content.
Ashtee L
J Pharm Pharmacol; 1973 Aug; 25(8):649-51. PubMed ID: 4148435
[No Abstract] [Full Text] [Related]
9. Proceedings: Effect of aporphine alkaloids on central dopamine receptors.
Kelly PH; Miller RJ; Neumeyer JL
Br J Pharmacol; 1975 Jun; 54(2):271P. PubMed ID: 1148551
[No Abstract] [Full Text] [Related]
10. Synthesis and biological activity of some aporphine derivatives related to apomorphine.
Saari WS; King SW
J Med Chem; 1974 Oct; 17(10):1086-90. PubMed ID: 4472802
[No Abstract] [Full Text] [Related]
11. Aporphines. 16. Action of aporphine alkaloids on locomotor activity in rats with 6-hydroxydopamine lesions of the nucleus accumbens.
Kelly PH; Miller RJ; Neumeyer JL
Eur J Pharmacol; 1976 Jan; 35(1):85-92. PubMed ID: 1253829
[TBL] [Abstract][Full Text] [Related]
12. Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates.
Iversen LL; Horn AS; Miller RJ
Adv Neurol; 1975; 9():197-212. PubMed ID: 167565
[No Abstract] [Full Text] [Related]
13. Catalepsy and stereotypies in rats treated with methadone; relation to striatal dopamine.
Ahtee L
Eur J Pharmacol; 1974 Jul; 27(2):221-30. PubMed ID: 4859239
[No Abstract] [Full Text] [Related]
14. Dopaminergic nature of apomorphine-induced pecking in pigeons.
Cheng HC; Long JP
Eur J Pharmacol; 1974 May; 26(2):313-20. PubMed ID: 4851427
[No Abstract] [Full Text] [Related]
15. Comparison of the dopaminergic effects of N-substituted aporphines.
Menon MK; Clark WG; Cannon JG
J Pharm Pharmacol; 1976 Oct; 28(10):778-81. PubMed ID: 10377
[No Abstract] [Full Text] [Related]
16. Evidence that methadone blocks dopamine receptors in the brain.
Sasame HA; Perez-Cruet J; Di Chiara G; Tagliamonte A; Tagliamonte P; Gessa GL
J Neurochem; 1972 Aug; 19(8):1953-7. PubMed ID: 4538006
[No Abstract] [Full Text] [Related]
17. [Serotoninergic implication l-tetrahydropalmatine-induced catalepsy in rats (author's transl)].
Jin GZ; Lin XJ; Yu LP; Xu J
Zhongguo Yao Li Xue Bao; 1980 Sep; 1(1):12-7. PubMed ID: 6175169
[No Abstract] [Full Text] [Related]
18. Synthetic aporphine alkaloids are potential therapeutics for Leigh syndrome.
Kobayashi M; Miyauchi A; Jimbo EF; Oishi N; Aoki S; Watanabe M; Yoshikawa Y; Akiyama Y; Yamagata T; Osaka H
Sci Rep; 2024 May; 14(1):11561. PubMed ID: 38773300
[TBL] [Abstract][Full Text] [Related]
19. 1,3-Bis(4-(p-methoxyphenyl)piperazinyl)-2-propanol (Ro 8-2580): a new monoamine depletor.
Burkard WP; Jalfre M; Blum JE; Haefely W
J Pharm Pharmacol; 1971 Aug; 23(8):646-8. PubMed ID: 4104427
[No Abstract] [Full Text] [Related]
20. Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
Johnson AM; Vigouret JM; Loew DM
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R40. PubMed ID: 4276573
[No Abstract] [Full Text] [Related]
[Next] [New Search]
